Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
US Market

Oncternal Therapeutics (ONCT) Ownership - Who Owns Oncternal Therapeutics?

453 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 10, 2024
xxxxxxxxxxxxx
$27651
Apr 01, 2024
xxxxxxxxxxxxx
$58562
Feb 27, 2024
xxxxxxxxxxxxx
$8859
Feb 27, 2024
xxxxxxxxxxxxx
$8859

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,877,614Insider232.38%47,180,432
204,817Insider6.92%1,405,045
172,049Insider5.81%1,180,256
139,050Institution4.70%953,883
139,050Institution4.70%953,883
74,319Institution2.51%509,828
71,947Insider2.43%493,556
48,468Insider1.64%332,490
48,175Insider1.63%330,481
45,936Insider1.55%315,121

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
139,050Institution4.70%953,883
74,319Institution2.51%509,828
22,418Institution0.76%153,787
11,590Institution0.39%79,507
1,701Institution0.06%11,669
1,612Institution0.05%11,061
1,458Institution0.05%10,002

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
107,989Institution3.65%820,716
31,061Institution1.05%236,064
14,404Institution0.49%99,244
8,864Institution0.30%61,073
2,624Institution0.09%18,079

FAQ

Who Owns Oncternal Therapeutics Inc (ONCT)?
Currently, no data Available
What percentage of Oncternal Therapeutics Inc (ONCT) stock is held by institutional investors?
Currently, no data Available
What percentage of Oncternal Therapeutics Inc (ONCT) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Oncternal Therapeutics Inc (ONCT)?
Joseph Hyde owns the most shares of Oncternal Therapeutics Inc (ONCT).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis